Intact-PTH [Parathyroid Hormone] ELISA [Enzyme-Linked ImmunoSorbent Assay] 7022Recalls & reported problems
Biomerica, Inc. · The Biomerica Intact-PTH ELISA is intended for the quantitative determination of Intact-PTH (Parathyroid Hormone) in human serum. This assay is intended for in vitro diagnostic use. · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08305900070224), received between Dec 5, 2016 and Dec 5, 2016 — classified as 2 malfunctions.
The most frequently reported specific device problem is “Output Problem” (2 reports).
1 other recall cover devices cleared under the same FDA submission (K974306); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Output Problem2
Patient problems
- No Patient Involvement2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 5, 2016Output Problem; Output Problem
THE POTENTIAL ISSUE IS ASSOCIATED WITH HIGH BACKGROUND BEING OBSERVED FOR CALIBRATOR A. ELEVATED OPTICAL DENSITY (OD 450 NM) OF CALIBRATOR A MAY CAUSE LOSS OF SEPARATION BETWEEN CALIBRATORS A AND B, WHICH MAY IMPACT THE ASSAY CALIBRATION. LOSS OF SEPARATION WAS OBSERVED FROM KIT LOT 2494, 2494B.
Patient problems: No Patient Involvement
MAUDE report 6145532 ↗MalfunctionDec 5, 2016Output Problem; Output Problem
THE POTENTIAL ISSUE IS ASSOCIATED WITH HIGH BACKGROUND BEING OBSERVED FOR CALIBRATOR A. ELEVATED OPTICAL DENSITY (OD 450 NM) OF CALIBRATOR A MAY CAUSE LOSS OF SEPARATION BETWEEN CALIBRATORS A AND B, WHICH MAY IMPACT THE ASSAY CALIBRATION. LOSS OF SEPARATION HAS BEEN REPORTED FROM KIT LOT NUMBER 2488.
Patient problems: No Patient Involvement
MAUDE report 6145519 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K974306. One submission often covers many models, so check the product and lot details in each record.
- Z-1520-2018 · Oct 26, 2016 · TerminatedQuidel MicroVue Intact PTH EIA, Model 8044. An enzyme immunoassay for the quantification of Intact Parathyroid Hormone (PTH) in serum.
Other Radioimmunoassay, Parathyroid Hormone devices
- VITROS 6802892Ortho Clinical Diagnostics · RADIOIMMUNOASSAY, PARATHYROID HORMONE1 recall155 reports
- Access Intact PTH A16972Beckman Coulter, Inc. · Radioimmunoassay, Parathyroid Hormone2 recalls8 reports
- IMMULITE® 2000 Systems IPT Intact PTH 10381441Siemens Healthcare Diagnostics Products Ltd · RADIOIMMUNOASSAY, PARATHYROID HORMONE1 recall18 reports
- Future Diagnostics 4K-IPT-00Future Diagnostics Solutions B.V. · RADIOIMMUNOASSAY, PARATHYROID HORMONE1 recall0 reports
- IMMULITE® 2000 Systems IPT Intact PTH 10381442Siemens Healthcare Diagnostics Products Ltd · RADIOIMMUNOASSAY, PARATHYROID HORMONE1 recall0 reports
- ADVIA Centaur® iPTH 10492368Siemens Healthcare Diagnostics Inc. · RADIOIMMUNOASSAY, PARATHYROID HORMONE23 reports
- Elecsys PTH 07251068190Roche Diagnostics GmbH · RADIOIMMUNOASSAY, PARATHYROID HORMONE21 reports
- VITROS 6900052Ortho Clinical Diagnostics · RADIOIMMUNOASSAY, PARATHYROID HORMONE21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page